| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/28/2003 | CA2399553A1 Quiescently frozen ice products |
| 02/27/2003 | WO2003016340A1 Derp1 and proderp1 allergen derivatives |
| 02/27/2003 | WO2003015936A1 Nanogels and their production using liposomes as reactors |
| 02/27/2003 | WO2003015839A2 Devices for intrabody delivery of molecules and systems and methods utilizing same |
| 02/27/2003 | WO2003015831A1 Gas microsphere liposome composites |
| 02/27/2003 | WO2003015824A1 Sustained-release medicinal compositions |
| 02/27/2003 | WO2003015823A1 Novel microemulsion and micelle systems for solubilizing drugs |
| 02/27/2003 | WO2003015822A1 5-cnac as oral delivery agent for parathyroid hormone fragments |
| 02/27/2003 | WO2003015821A1 Topical composition, topical composition precursor, and methods for manufacturing and using |
| 02/27/2003 | WO2003015820A1 GnRH AGONIST COMBINATION DRUGS |
| 02/27/2003 | WO2003015817A2 Oral immunoglobulin treatment for inflammatory bowel disease |
| 02/27/2003 | WO2003015816A1 Immunomodulatory oligonucleotide formulations and methods for use thereof |
| 02/27/2003 | WO2003015795A1 Physiological method of improving vision |
| 02/27/2003 | WO2003015793A1 Delayed and sustained drug release |
| 02/27/2003 | WO2003015783A1 Method of treating alcoholism or alcohol abuse |
| 02/27/2003 | WO2003015782A2 Receptor-adapted nicotine withdrawal by anti-cholinergic and anti-noradrenergic blockage |
| 02/27/2003 | WO2003015779A2 Matrix controlled transdermal therapeutic system for the use of pramipexole and ropinirole |
| 02/27/2003 | WO2003015760A1 Use of dmso in the treatment of neurodegenerative diseases caused by prions |
| 02/27/2003 | WO2003015759A2 Treatment of hyperproliferative conditions of body surfaces |
| 02/27/2003 | WO2003015758A1 Sustained release micropellets and process for producing the same |
| 02/27/2003 | WO2003015757A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 02/27/2003 | WO2003015756A1 Preparation of microparticles |
| 02/27/2003 | WO2003015755A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 02/27/2003 | WO2003015754A1 Devices including protein matrix materials and methods of making and using same |
| 02/27/2003 | WO2003015753A1 Liposome preparations |
| 02/27/2003 | WO2003015752A1 The process for preparing isotonic topical antibiotic ophthalmic formulation with improved therapeutic effect |
| 02/27/2003 | WO2003015751A1 Pharmaceutical composition for nasal delivery of estradiol and norethisterone |
| 02/27/2003 | WO2003015750A1 Propellant-based microparticle formulations |
| 02/27/2003 | WO2003015749A1 Breath freshening film |
| 02/27/2003 | WO2003015748A2 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 02/27/2003 | WO2003015747A1 Method to treat pulmonary hypoplasia in the newborn |
| 02/27/2003 | WO2003015745A1 Expandable gastric retention device |
| 02/27/2003 | WO2003015744A1 Chitin microparticles and their medical uses |
| 02/27/2003 | WO2003015743A1 Immunisation by means of the local implantation of antigens which are irreversibly fixed to a bioadherent |
| 02/27/2003 | WO2003015729A1 Topical composition for follicular delivery of an ornithine decarboxylase inhibitor |
| 02/27/2003 | WO2003015707A2 Method for treating lung cancers |
| 02/27/2003 | WO2003015701A2 Lipobeads and their production |
| 02/27/2003 | WO2003015699A2 Topical compositions and methods for treating pain |
| 02/27/2003 | WO2003015698A2 Application of lipid vehicles and use for drug delivery |
| 02/27/2003 | WO2003015690A2 Method for treating primary insomnia |
| 02/27/2003 | WO2003015678A1 Composition and transdermal drug delivery device |
| 02/27/2003 | WO2003015667A1 Method and intra sclera implant for treatment of glaucoma and presbyopia |
| 02/27/2003 | WO2003015661A2 Treatment patch |
| 02/27/2003 | WO2003015656A2 Oral care substance delivery strip |
| 02/27/2003 | WO2003015531A2 Pharmaceutical formulation containing dye |
| 02/27/2003 | WO2003015521A1 Treatment of cancers by inhalation of stable platinum-containing formulations |
| 02/27/2003 | WO2003002123A3 Therapeutic combinations for the treatment of hormone deficiencies |
| 02/27/2003 | WO2003000656A3 Antisense modulation of transforming growth factor beta receptor ii expression |
| 02/27/2003 | WO2002100862A3 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 02/27/2003 | WO2002098413A3 Pharmaceutical compositions comprising orlistat and fatty acids and/or salts thereof |
| 02/27/2003 | WO2002083135A3 Use of buprenorphine for the manufacture of a transdermal delivery device for the treatment of urinary incontinence, especially urge incontinence |
| 02/27/2003 | WO2002078611A3 Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof |
| 02/27/2003 | WO2002078601A3 Drug release from polymer matrices through mechanical stimulation |
| 02/27/2003 | WO2002072026A3 In situ langerhans cell vaccine |
| 02/27/2003 | WO2002072018A3 A cream-t0-powder dermatological composition |
| 02/27/2003 | WO2002064123A3 Method and device for producing thin wafers from a film of active ingredients |
| 02/27/2003 | WO2002062321A3 Method for producing a floating tablet containing an active principle |
| 02/27/2003 | WO2002060411A3 Process for production of nanoparticles and microparticles by spray freezing into liquid |
| 02/27/2003 | WO2002060391A3 Pharmaceutical composition for the prevention and treatment of scar tissue |
| 02/27/2003 | WO2002056908A3 Artificial antigen-presenting cells |
| 02/27/2003 | WO2002056863A3 Sustained release drug delivery devices |
| 02/27/2003 | WO2002055093A3 Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages |
| 02/27/2003 | WO2002055011A3 Amphiphilic derivatives for the production of vesicles, micelles and complexants, and precursors thereof |
| 02/27/2003 | WO2002053220A3 Low profile pivoting joint infusion assembly |
| 02/27/2003 | WO2002053168A3 Sterilising pill |
| 02/27/2003 | WO2002049611A3 Ophthalmic lubricating solution adapted for use in lasik surgery |
| 02/27/2003 | WO2002044336A3 Method of making a protein polymer and uses of the polymer |
| 02/27/2003 | WO2002043695A3 Stable, aerosolizable suspensions of proteins (e.g. insulin, dnase) in ethanol |
| 02/27/2003 | WO2002041844A3 Chemotherapeutic composition using nanocrystalline calcium phosphate paste |
| 02/27/2003 | WO2002039993A3 Pharmaceutival preparations comprising corticosteroids and antiinfective agents |
| 02/27/2003 | WO2002028379A3 Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases |
| 02/27/2003 | WO2002017919A3 Use of threo-methylphenidate compounds to enhance memory |
| 02/27/2003 | WO2002015877A3 Methods and compositions for targeted delivery |
| 02/27/2003 | WO2002011711A3 Formulations of mometasone and a bronchodilator for pulmonary administration |
| 02/27/2003 | WO2002009674A3 Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds |
| 02/27/2003 | US20030040790 Stent coating |
| 02/27/2003 | US20030040537 Treatment of migraine headache |
| 02/27/2003 | US20030040524 Pyrimidine compounds and methods for making and using the same |
| 02/27/2003 | US20030040509 Methods and compositions for treating diseases associated with excesses in ACE |
| 02/27/2003 | US20030040507 Pharmaceutical composition comprising ifosfamide and carnitine |
| 02/27/2003 | US20030040497 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 02/27/2003 | US20030040487 Polymer complexes of glucuronoglucanes |
| 02/27/2003 | US20030040462 Spraying into a hot gas stream an aqueous mixture of the material and a carrier substance which is water-soluble or water-swellable, thereby drying the mixture to particles which contain the material and the carrier substance |
| 02/27/2003 | US20030040180 Heating nanomaterial comprising porous silicon; melting; bonding strength; low temperature welding |
| 02/27/2003 | US20030039960 Transferring therapeutic agent into body cavity of mammal; prepare therapeutic agent, obtain mammal, inject mammal, monitor mamamlian response to therapeutic agent |
| 02/27/2003 | US20030039956 Compositions and methods for increasing the oral absorption of antimicrobials |
| 02/27/2003 | US20030039777 Method of producing structures using centrifugal forces |
| 02/27/2003 | US20030039740 Composition for enteral nutrition comprising fibres |
| 02/27/2003 | US20030039720 Containing agar |
| 02/27/2003 | US20030039699 Coating water soluble drug; high density active materials; uniform, stable |
| 02/27/2003 | US20030039698 Sustained-release preparation |
| 02/27/2003 | US20030039697 Matrices containing nitric oxide donors and reducing agents and their use |
| 02/27/2003 | US20030039693 Three-dimensional biocatalyst |
| 02/27/2003 | US20030039692 Sustained release oral formulations |
| 02/27/2003 | US20030039691 Compression coatings |
| 02/27/2003 | US20030039690 Controlling concentration of enzyme inhibitor in blood; enteric coating |
| 02/27/2003 | US20030039689 Prodrug in polymer matrix; insertion into body |
| 02/27/2003 | US20030039688 Extending the duration of drug release within the stomach during the fed mode |
| 02/27/2003 | US20030039687 Using Carbomer |
| 02/27/2003 | US20030039686 Increased absorption; aqueous solution containing fatty acid, or salt thereof |